Why Scientists Just Launched the First Human Trial of a Vaccine Designed Entirely by AI
In a landmark development for global public health and computational biology, scientists have successfully completed the first-in-human clinical trial of a vaccine whose active ingredient was designed entirely by artificial intelligence. On June 5, 2026, researchers from the University of Cambridge ...